https://www.reuters.com/article/us-health-coronavirus-serum-institute-idUSKBN2670PP

4 0 Report

FILE PHOTO: A test tube labelled with the Vaccine is seen in front of Covid-19 and stock graph logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo. MUMBAI/BENGALURU (Reuters) - Serum Institute of India has received Indian regulatory approval to resume local clinical trials of AstraZeneca’s potential COVID-19 vaccine, a source familiar with the matter said on Wednesday. The approval came from the Drugs Controller General of India, the source said. AstraZeneca has resumed British clinical trials of the vaccine - one of the most advanced in development for COVID-19 - after they were paused earlier this month following a serious side effect in a trial participant. Full story

6 days ago, 16 September

0
wait